Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma 2Hematologic Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Healthy Volunteer 1Genetic Diseases, Inborn 1Breast Neoplasms 1

Interventions

Cyclophosphamide 89Peripheral Blood Stem Cell Transplantation 75Etoposide 55Filgrastim 53fludarabine phosphate 43Rituximab 42Radiotherapy 42Cyclosporine 34Busulfan 33Mycophenolic Acid 30Melphalan 29Whole-Body Irradiation 27Tacrolimus 25Cytarabine 25Methotrexate 24Vincristine 23Antilymphocyte Serum 23Prednisone 21Carmustine 20Methylprednisolone 19Doxorubicin 19sargramostim 14Ifosfamide 13Carboplatin 13Granulocyte Colony-Stimulating Factor 12Paclitaxel 11Cisplatin 11aldesleukin 9Thiotepa 9Therapeutics 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Large-Cell, Immunoblastic × keyhole-limpet hemocyanin × Clear all
NCT00004197 2023-09-07

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

University of Nebraska

Phase 2 Completed
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡